Report copyright - Cardiovascular Disease and · 2020. 8. 5. · reduce risk based on drug effects and individual factors. SGLT-2i - Empagliflozin (Jardiance), canagliflozin (Invokana) and dapagliflozin
Please pass captcha verification before submit form